mhd kher alsaeyd ahmad

Dr. mhd kher alsaeyd ahmad


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAndreea Sălcudean
Andreea Sălcudean
RPRamona Amina Popovici
Ramona Amina Popovici
DPDana Emanuela T Pitic
Dana Emanuela T Pitic
DSDiana Cristina Sarbu
Diana Cristina Sarbu
ABAdela Boroghina
Adela Boroghina
VEVirgil Radu Enatescu
Virgil Radu Enatescu
The relationship between neuroinflammation and depression is a complex area of research that has garnered significant attention in recent years. Neuroinflammation, characterized by the activation of glial cells and the release of pro-inflammatory cytokines, has been implicated in the pathophysiology of depression. The relationship between neuroinflammation and depression is bidirectional; not only can inflammation contribute to the onset of depressive symptoms, but depression itself can also exacerbate inflammatory responses, creating a vicious cycle that complicates treatment and recovery. The present comprehensive review aimed to explore the current findings on the interplay between neuroinflammation and depression, as well as the mechanisms, risk factors, and therapeutic implications. The mechanisms by which neuroinflammation induces depressive-like behaviors are diverse. Neuroinflammation can increase pro-inflammatory cytokines, activate the hypothalamus–pituitary–adrenal (HPA) axis, and impair serotonin synthesis, all of which contribute to depressive symptoms. Furthermore, the activation of microglia has been linked to the release of inflammatory mediators that can disrupt neuronal function and contribute to mood disorders. Stress-induced neuroinflammatory responses can lead to the release of pro-inflammatory cytokines that not only affect brain function but also influence behavior and mood. Understanding these mechanisms is crucial for developing targeted therapies that can mitigate the effects of neuroinflammation on mood disorders.

18 September 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
MAmhd kher alsaeyd ahmad
mhd kher alsaeyd ahmad
Stefania DinuStefania Dinu
Stefania Dinu
SDStefania Irina Dumitrel
Stefania Irina Dumitrel
RPRamona Amina Popovici
Ramona Amina Popovici
DCDoina Chioran
Doina Chioran
Background: Thymol has been considered a possible bioactive phytocompound in dentistry due to its antimicrobial, antibiofilm, antifungal and anti-inflammatory properties. The current narrative review aims to critically review the present evidence on biological properties, mechanism of action, formulations and applications of thymol in preventive dentistry, periodontics, endodontics, prosthodontics and emerging dental materials and delivery systems, highlighting the current limitations and future perspectives. Methods: A literature search was carried out on PubMed, Scopus, ScienceDirect and Google Scholar databases. The search included publications related to thymol and its applications in oral health and dentistry. Results: The most recent evidence supports the adjunctive use of thymol in preventive and periodontal oral-care products, particularly in essential oil-based formulations. Moreover, recent advances in nanoformulations and dental materials suggest that its therapeutic potential can be further improved by optimized delivery systems. Conclusions: Thymol is a naturally occurring active compound that offers numerous benefits in various dental applications due to its multifaceted properties and safety profile. Preliminary and clinical evidence is encouraging, but more standardized clinical studies are needed to better define its long-term efficacy, optimal formulations, therapeutic concentrations, and clinical applicability in dentistry.

Verified
Journal Article
Open access
PDF file
MAmhd kher alsaeyd ahmad
mhd kher alsaeyd ahmad
DCDoina Chioran
Doina Chioran
DPDana Emanuela T Pitic
Dana Emanuela T Pitic
Elena Alina MoacaElena Alina Moaca
Elena Alina Moaca
DADiana Haj Ali
Diana Haj Ali
MVMirela Voicu
Mirela Voicu
Background/Objectives: Plant-mediated silver nanoparticles (AgNPs) are promising components for oral biomaterials because of their antimicrobial potential; however, their biological behavior depends strongly on the phytochemical matrix, physicochemical characteristics, and exposure concentration. This study aimed to evaluate silver nanoparticles formulations synthesized using turmeric powder-derived Curcuma longa ethanolic and aqueous extracts, with emphasis on physicochemical characterization, antibacterial activity against oral-relevant Gram-positive bacteria, cytocompatibility toward human gingival fibroblasts (HGF-1), and acute in ovo vascular compatibility. Methods: AgCUR-EtOH NPs and AgCUR-H2O NPs were synthesized using CUR-EtOH and CUR-H2O extracts as reducing and stabilizing matrices. The resulting formulations were characterized by UV–visible spectroscopy (UV-Vis), dynamic light scattering (DLS), zeta-potential analysis, X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and energy-dispersive X-ray spectroscopy (EDX). Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined against Streptococcus mutans, Streptococcus oralis, and Staphylococcus aureus. Cytocompatibility was evaluated in HGF-1 human gingival fibroblasts after 24 h exposure to 1–10 µg/mL using complementary viability, lysosomal, mitochondrial, and fluorescence-based assays. Acute vascular irritation was assessed using the hen’s egg test–chorioallantoic membrane (HET-CAM) assay. Results: Both formulations exhibited broad, polydisperse hydrodynamic distributions and negative apparent zeta potentials. AgCUR-H2O NPs showed a lower Z-average diameter than AgCUR-EtOH NPs under their respective solvent-specific measurement conditions. XRD pattern revealed heterogeneous crystalline compositions dominated by residual AgNO3, together with weaker contributions consistent with metallic Ag and a possible minor oxidized silver phase. FTIR spectra demonstrated extract-derived organic functional groups and prominent nitrate-associated bands. TEM/EDX confirmed Ag-containing nanostructures with approximate size ranges of 15–175 nm for AgCUR-EtOH NPs and 15–150 nm for AgCUR-H2O NPs. S. mutans was the most susceptible microorganism, with MIC values of 9 and 7 µg/mL and MBC values of 88 and 62 µg/mL for AgCUR-EtOH NPs and AgCUR-H2O NPs, respectively. AgCUR-H2O NPs consistently showed lower MIC and MBC values against all tested strains, but also produced a more pronounced concentration-dependent reduction in HGF-1 viability. At 10 µg/mL, cell viability was 71.88% for AgCUR-EtOH NPs and 52.14% for AgCUR-H2O NPs. Both formulations showed low acute irritation potential in ovo, with irritation scores of 1.06 and 0.69, respectively. Conclusions: The two CUR-AgNP formulations exhibited distinct physicochemical, antibacterial, and cellular response profiles under the tested conditions. At equivalent concentrations expressed as total dried formulation mass, AgCUR-H2O NPs yielded lower MIC and MBC values against the tested bacterial strains, whereas AgCUR-EtOH NPs produced a less pronounced reduction in HGF-1 viability. Because the powders were not quantitatively normalized for total silver, extract-derived organic fraction, or residual precursor content, these differences cannot be attributed exclusively to nanoparticle properties or to the extraction solvent and should not be interpreted as evidence of the intrinsic superiority of either formulation. Both formulations showed low acute vascular irritation. Further quantitative compositional, silver-release, and biofilm assessments are required before incorporation into oral biomaterial platforms.